Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
i3 Verticals
IIIV
$328M
| $11.4M | ﹤0.01% |
534,684
+542
| +0.1% | +$12.2K |
|
2302
GCM Grosvenor
GCMG
$827M
| $11.4M | ﹤0.01% |
1,004,614
+2,607
| +0.3% | +$28K |
|
|
NLOP
2303
Net Lease Office Properties
NLOP
$171M
| $11.4M | ﹤0.01% |
371,333
-5,970
| -2% | -$172K |
|
|
HTB
2304
HomeTrust Bancshares
HTB
$829M
| $11.4M | ﹤0.01% |
333,067
-11,159
| -3% | -$376K |
|
|
PLGO
2305
Pelagos Insurance Capital
PLGO
$2.11B
| $11.3M | ﹤0.01% |
627,616
+44,416
| +8% | +$784K |
|
2306
Capital City Bank Group
CCBG
$880M
| $11.3M | ﹤0.01% |
320,479
+7,773
| +2% | +$255K |
|
2307
Weave Communications
WEAV
$437M
| $11.3M | ﹤0.01% |
883,207
+101,580
| +13% | +$1.07M |
|
2308
Usana Health Sciences
USNA
$265M
| $11.3M | ﹤0.01% |
297,120
+12,898
| +5% | +$530K |
|
2309
Bioventus
BVS
$1.15B
| $11.2M | ﹤0.01% |
940,496
+65,374
| +7% | +$565K |
|
2310
Five Star Bancorp
FSBC
$1.12B
| $11.2M | ﹤0.01% |
377,347
+25,374
| +7% | +$709K |
|
|
CVGW
2311
DELISTED
Calavo Growers
CVGW
| $11.2M | ﹤0.01% |
392,977
-10,019
| -2% | -$245K |
|
2312
4D Molecular Therapeutics
FDMT
$576M
| $11.2M | ﹤0.01% |
1,036,545
-24,346
| -2% | -$404K |
|
|
TWKS
2313
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $11.2M | ﹤0.01% |
2,532,163
+829
| +0% | +$3.18K |
|
2314
Olema Pharmaceuticals
OLMA
$1.04B
| $11.2M | ﹤0.01% |
934,929
-125,170
| -12% | -$1.6M |
|
2315
Clearfield
CLFD
$384M
| $11.2M | ﹤0.01% |
286,215
-5,569
| -2% | -$217K |
|
2316
Kura Sushi USA
KRUS
$582M
| $11.1M | ﹤0.01% |
138,329
-942
| -0.7% | -$59.8K |
|
2317
Quanterix
QTRX
$113M
| $11.1M | ﹤0.01% |
858,667
+18,231
| +2% | +$244K |
|
|
CON
2318
Concentra Group Holdings
CON
$4.32B
| $11.1M | ﹤0.01% |
+497,310
| New | +$11.5M |
|
2319
Humacyte
HUMA
$196M
| $11.1M | ﹤0.01% |
2,040,218
+179,120
| +10% | +$1.18M |
|
2320
Varex Imaging
VREX
$778M
| $11.1M | ﹤0.01% |
929,004
+4,211
| +0.5% | +$53.6K |
|
2321
Inter&Co
INTR
$2.37B
| $11.1M | ﹤0.01% |
1,672,833
+1,361,258
| +437% | +$9.41M |
|
|
INST
2322
DELISTED
Instructure Holdings, Inc.
INST
| $11M | ﹤0.01% |
467,436
+6,840
| +1% | +$161K |
|
2323
Tiptree Inc
TIPT
$673M
| $11M | ﹤0.01% |
559,905
+7,974
| +1% | +$148K |
|
|
CLDT
2324
Chatham Lodging
CLDT
$573M
| $11M | ﹤0.01% |
1,285,326
+26,129
| +2% | +$221K |
|
2325
Dine Brands
DIN
$440M
| $10.9M | ﹤0.01% |
349,949
+3,584
| +1% | +$115K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.